| scholarly article | Q13442814 |
| P2093 | author name string | S Salminen | |
| E Moilanen | |||
| E Isolauri | |||
| T Arvola | |||
| Y Sütas | |||
| P2860 | cites work | Hay fever, hygiene, and household size | Q24674856 |
| Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis | Q28266324 | ||
| Regulation of immune responses by TGF-beta | Q28271433 | ||
| Atopic disorders: a default pathway in the absence of infection? | Q33667785 | ||
| Transforming growth factor-beta in breast milk: a potential regulator of atopic disease at an early age. | Q34506160 | ||
| Probiotics: a novel approach in the management of food allergy | Q34738168 | ||
| Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation | Q35350454 | ||
| Prevalence of asthma and allergic disorders among children in united Germany: a descriptive comparison | Q35824750 | ||
| CD4(+) T helper cells engineered to produce latent TGF-beta1 reverse allergen-induced airway hyperreactivity and inflammation | Q37303070 | ||
| Pathogenesis of allergic rhinitis | Q41355308 | ||
| Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions | Q42538144 | ||
| Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma | Q44385702 | ||
| Functional food science and gastrointestinal physiology and function. | Q54113158 | ||
| Soluble CD4: a Link Between Specific Immune Mechanisms and Non-Specific Inflammatory Responses? | Q58861603 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | probiotics | Q1816730 |
| P304 | page(s) | 1604-10 | |
| P577 | publication date | 2000-11-01 | |
| P1433 | published in | Clinical & Experimental Allergy | Q5133747 |
| P1476 | title | Probiotics in the management of atopic eczema | |
| P478 | volume | 30 |
| Q59180794 | A Longitudinal Analysis on the Association Between Antibiotic Use, Intestinal Microflora, and Wheezing During the First Year of Life |
| Q58122112 | A Probiotic Mixture Regulates T Cell Balance and Reduces Atopic Dermatitis Symptoms in Mice |
| Q38849448 | A Randomized Controlled Trial Assessing Growth of Infants Fed a 100% Whey Extensively Hydrolyzed Formula Compared With a Casein-Based Extensively Hydrolyzed Formula |
| Q36830447 | A molecular basis for bifidobacterial enrichment in the infant gastrointestinal tract |
| Q82475930 | A non-hydrolyzed, fermented milk formula reduces digestive and respiratory events in infants at high risk of allergy |
| Q37332655 | A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice. |
| Q33590786 | A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients |
| Q28307749 | A randomized prospective double blind controlled trial on effects of long-term consumption of fermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/or rhinitis |
| Q42114946 | Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? |
| Q40725779 | Adhesion of lactic acid bacteria to caco-2 cells and their effect on cytokine secretion. |
| Q26750443 | Allergic diseases among children: nutritional prevention and intervention |
| Q37788680 | Altered Host-Microbe Interaction in HIV: A Target for Intervention with Pro- and Prebiotics |
| Q53544416 | Amelioration of ovalbumin induced allergic symptoms in Balb/c mice by potentially probiotic strains of lactobacilli. |
| Q79218992 | American Association of Clinical Endocrinologists Medical Guidelines for the Clinical Use of Dietary Supplements and Nutraceuticals |
| Q83142486 | Anti-atopic dermatitis effects and the mechanism of lactic acid bacteria isolated from Mongolian fermented milk |
| Q42322681 | Anti-diabetic effects of lactic acid bacteria in normal and type 2 diabetic mice |
| Q44543214 | Antioxidative probiotic fermented goats' milk decreases oxidative stress-mediated atherogenicity in human subjects |
| Q26779610 | Assessing worldwide research activity on probiotics in pediatrics using Scopus database: 1994-2014 |
| Q35039235 | Association between funding source, methodological quality and research outcomes in randomized controlled trials of synbiotics, probiotics and prebiotics added to infant formula: a systematic review |
| Q34396961 | Atopic dermatitis and the 'hygiene hypothesis': too clean to be true? |
| Q57072087 | Atopisches Ekzem |
| Q34899090 | Bacterial components plus vitamin D: the ultimate solution to the asthma (autoimmune disease) epidemic? |
| Q35826771 | Bacterial munch for infants: potential pediatric therapeutic interventions of probiotics |
| Q35056256 | Bifidobacteria: their impact on gut microbiota composition and their applications as probiotics in infants |
| Q34489621 | Bifidobacterium breve with α-linolenic acid and linoleic acid alters fatty acid metabolism in the maternal separation model of irritable bowel syndrome |
| Q34727997 | Bifidobacterium fermented milk and galacto-oligosaccharides lead to improved skin health by decreasing phenols production by gut microbiota |
| Q38410204 | Bugs for atopy: the Lactobacillus rhamnosus GG strategy for food allergy prevention and treatment in children. |
| Q35649234 | Can we prevent allergy? |
| Q37335576 | Catabolism of glucose and lactose in Bifidobacterium animalis subsp. lactis, studied by 13C Nuclear Magnetic Resonance |
| Q48052777 | Children with atopic dermatitis show clinical improvement after Lactobacillus exposure |
| Q36834812 | Clinical Use of Probiotics in Pediatric Allergy (CUPPA): A World Allergy Organization Position Paper |
| Q26769032 | Clinical Uses of Probiotics |
| Q37285699 | Clinical efficacy and mechanism of probiotics in allergic diseases |
| Q34586857 | Clinical indications for probiotics: an overview |
| Q82348866 | Comparative effects of six probiotic strains on immune function in vitro |
| Q57718828 | Comparison of Fecal Microbiota and Polyamine Concentration in Adult Patients with Intractable Atopic Dermatitis and Healthy Adults |
| Q33505868 | Comparison of gut microbiota and allergic reactions in BALB/c mice fed different cultivars of rice |
| Q43609061 | Consensus guidelines for the management of atopic dermatitis: an Asia-Pacific perspective. |
| Q35215800 | Constitutive delivery of bovine beta-lactoglobulin to the digestive tracts of gnotobiotic mice by engineered Lactobacillus casei |
| Q37671347 | Cow's milk allergy: from allergens to new forms of diagnosis, therapy and prevention |
| Q35962381 | Current and potential uses of probiotics |
| Q38008468 | Designing probiotics with respect to the native microbiome. |
| Q59281001 | Development of a fermented goat's milk containing probiotic bacteria |
| Q26991504 | Development of microencapsulation delivery system for long-term preservation of probiotics as biotherapeutics agent |
| Q57072093 | Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report |
| Q24242563 | Dietary exclusions for established atopic eczema |
| Q35790934 | Dietary modification of atopic disease: Use of probiotics in the prevention of atopic dermatitis |
| Q39751049 | Distinct pattern of commensal gut microbiota in toddlers with eczema |
| Q36924911 | Diversity of the gut microbiota and eczema in early life |
| Q37842653 | Do probiotics offer opportunities to manipulate the periodontal oral microbiota? |
| Q33435312 | Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults. |
| Q83711045 | Early exposure to probiotics in a canine model of atopic dermatitis has long-term clinical and immunological effects |
| Q81196211 | Effect of Lactobacillus rhamnosus GG on rBet v1 and rMal d1 specific IgA in the saliva of patients with birch pollen allergy |
| Q47228362 | Effect of Multi-Microbial Probiotic Formulation Bokashi on Pro- and Anti-Inflammatory Cytokines Profile in the Serum, Colostrum and Milk of Sows, and in a Culture of Polymorphonuclear Cells Isolated from Colostrum. |
| Q34633825 | Effect of a synbiotic yogurt on levels of fecal bifidobacteria, clostridia, and enterobacteria. |
| Q26768298 | Effect of probiotics in prevention and treatment of allergic diseases in children |
| Q44082289 | Effect of probiotics on allergic rhinitis in Df, Dp or dust-sensitive children: a randomized double blind controlled trial |
| Q46796730 | Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life |
| Q35685182 | Effects of intestinal microflora and the environment on the development of asthma and allergy |
| Q35284723 | Effects of probiotics on atopic dermatitis: a randomised controlled trial |
| Q36057031 | Effects of probiotics on the prevention of atopic dermatitis |
| Q45753524 | Efficacy of probiotics in the treatment of pediatric atopic dermatitis: a meta-analysis of randomized controlled trials |
| Q42850718 | Efficient production and secretion of bovine beta-lactoglobulin by Lactobacillus casei |
| Q37046636 | Emerging treatment of atopic dermatitis |
| Q40565252 | Epidemiology of food allergies |
| Q46620197 | Evaluation of the preventative effects exerted by Lactobacillus fermentum in an experimental model of septic shock induced in mice. |
| Q35819732 | Extensively hydrolysed casein formula supplemented with Lactobacillus rhamnosus GG maintains hypoallergenic status: randomised double-blind, placebo-controlled crossover trial |
| Q49442283 | Fecal Microbiota Transplantation, Commensal Escherichia coli and Lactobacillus johnsonii Strains Differentially Restore Intestinal and Systemic Adaptive Immune Cell Populations Following Broad-spectrum Antibiotic Treatment |
| Q89621140 | Galectin-9 Induced by Dietary Probiotic Mixture Regulates Immune Balance to Reduce Atopic Dermatitis Symptoms in Mice |
| Q36531260 | Gastrointestinal microflora: probiotics |
| Q34403854 | General introduction to the importance of genomics in food biotechnology and nutrition |
| Q50616650 | Growth and tolerance of healthy term infants receiving hydrolyzed infant formulas supplemented with Lactobacillus rhamnosus GG: randomized, double-blind, controlled trial |
| Q43331511 | Growth during the first 6 months of life in infants using formula enriched with Lactobacillus rhamnosus GG: double-blind, randomized trial |
| Q41854107 | Growth phase-associated changes in the proteome and transcriptome of Lactobacillus rhamnosus GG in industrial-type whey medium. |
| Q64266581 | Gut Microbiome as Target for Innovative Strategies Against Food Allergy |
| Q34835307 | Gut bacteria and health foods--the European perspective |
| Q35670894 | Gut microbiota and inflammation |
| Q26827715 | Gut microbiota as potential therapeutic target for the treatment of cow's milk allergy |
| Q35929571 | Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study |
| Q34899441 | Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity? |
| Q27024802 | Health benefits of probiotics: a review |
| Q38173392 | Health effects of probiotics on the skin. |
| Q36201410 | Hope for the hygiene hypothesis: when the dirt hits the fan. |
| Q64069149 | Human Gut Microbiome Response Induced by Fermented Dairy Product Intake in Healthy Volunteers |
| Q28743610 | Identification and characterisation of an iron-responsive candidate probiotic |
| Q35098833 | Immune deviation and the hygiene hypothesis: a review of the epidemiological evidence |
| Q85856203 | Immune-modulatory effect of probiotic Bifidobacterium lactis NCC2818 in individuals suffering from seasonal allergic rhinitis to grass pollen: an exploratory, randomized, placebo-controlled clinical trial |
| Q35600566 | Immunological effects of probiotics with special reference to lactobacilli |
| Q37299532 | Immunomodulation by food: promising concept for mitigating allergic disease? |
| Q59353347 | Immunomodulatory effects of the intake of fermented milk with Lactobacillus casei DN114001 in lactating mothers and their children |
| Q35596011 | Immunomodulatory mechanisms of lactobacilli |
| Q35581731 | Immunotherapy with mycobacteria |
| Q34863656 | Impact of orally administered lozenges with Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis BB-12 on the number of salivary mutans streptococci, amount of plaque, gingival inflammation and the oral microbiome in healthy adults |
| Q37224547 | In vitro and in vivo survival and colonic adhesion of Pediococcus acidilactici MTCC5101 in human gut. |
| Q36059336 | Infections and atopy: an exploratory study for a meta-analysis of the "hygiene hypothesis". |
| Q37544889 | Inflammatory disease processes and interactions with nutrition |
| Q51662302 | Influence of orally administered Lactobacillus GG on respiratory immune response in a murine model of diet-induced obesity. |
| Q74379671 | Influence of probiotic supplemented infant formula on composition of plasma lipids in atopic infants |
| Q36797288 | Intestinal bacteria and ageing |
| Q35028029 | Inventing probiotic functional foods for patients with allergic disease. |
| Q34566921 | Is the effect of probiotics on atopic dermatitis confined to food sensitized children? |
| Q38128232 | Is there a role for probiotics in the prevention or treatment of food allergy? |
| Q34442928 | L. plantarum, L. salivarius, and L. lactis attenuate Th2 responses and increase Treg frequencies in healthy mice in a strain dependent manner |
| Q82997042 | Lactic acid bacteria as adjuvants for sublingual allergy vaccines |
| Q21128674 | Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland |
| Q54592118 | Lactobacillus rhamnosus GG and Streptococcus thermophilus induce suppressor of cytokine signalling 3 (SOCS3) gene expression directly and indirectly via interleukin-10 in human primary macrophages. |
| Q33276925 | Laser acupuncture and probiotics in school age children with asthma: a randomized, placebo-controlled pilot study of therapy guided by principles of Traditional Chinese Medicine |
| Q36153923 | Lessons from the genomes of bifidobacteria |
| Q43366024 | Linking the Gut Microbial Ecosystem with the Environment: Does Gut Health Depend on Where We Live? |
| Q36273383 | Live bacterial cells as orally delivered therapeutics |
| Q37592718 | Long-term safety assessment in children who received hydrolyzed protein formulas with Lactobacillus rhamnosus GG: a 5-year follow-up |
| Q45213834 | Meta-analysis of probiotics and/or prebiotics for the prevention of eczema |
| Q35131619 | Microbial products in allergy prevention and therapy. |
| Q49910570 | Microbiome, atopic eczema and blockade of type 2 immunity |
| Q37983881 | Milk, milk products, and disease free health: an updated overview. |
| Q35069347 | Mode of delivery and cord blood cytokines: a birth cohort study |
| Q24808820 | Modulation of Immune Functions by Foods |
| Q36209726 | Mucosal immunity and allergic responses: lack of regulation and/or lack of microbial stimulation? |
| Q39193673 | Neonatal supplementation of processed supernatant from Lactobacillus rhamnosus GG improves allergic airway inflammation in mice later in life |
| Q35680646 | New strategies in the treatment and prevention of allergic diseases |
| Q34984694 | New therapeutic approach in the management of intestinal disease: probiotics in intestinal disease in paediatric age. |
| Q53611721 | No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. |
| Q35114267 | Non-alcoholic fatty liver disease: lumen–liver interactions and possible role for probiotics |
| Q36545386 | Non-digestible oligosaccharides with prebiotic properties. |
| Q34984683 | Novel probiotics for the management of allergic inflammation |
| Q46947410 | Oral administration of Bifidobacterium breve attenuates UV-induced barrier perturbation and oxidative stress in hairless mice skin |
| Q50773084 | Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study |
| Q37658978 | Perceptions of medical sciences students towards probiotics |
| Q51761758 | Perinatal maternal application of Lactobacillus rhamnosus GG suppresses allergic airway inflammation in mouse offspring. |
| Q38114513 | Potential of Bambara groundnut (Vigna subterranea (L.) Verdc) milk as a probiotic beverage-a review. |
| Q24681377 | Potential uses of probiotics in clinical practice |
| Q38181857 | Prebiotics and probiotics: the prevention and reduction in severity of atopic dermatitis in children |
| Q40551790 | Prebiotics in infant milk formulas: new perspectives |
| Q33785236 | Predominant genera of fecal microbiota in children with atopic dermatitis are not altered by intake of probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp. lactis Bi-07. |
| Q39429596 | Prevention and Management of Cow's Milk Allergy in Non-Exclusively Breastfed Infants |
| Q34958399 | Preventive measures and their effects. Results from cohort studies. |
| Q35184885 | Primary and secondary prevention of allergic airway disease. |
| Q34938619 | Pro and anti: the biotics of allergic disease |
| Q38702214 | Probiotic Formulations: Application and Status as Pharmaceuticals-A Review |
| Q58236981 | Probiotic Lactobacillus strains: in vitro and in vivo studies |
| Q37212931 | Probiotic Leuconostoc mesenteroides ssp. cremoris and Streptococcus thermophilus induce IL-12 and IFN-gamma production. |
| Q38097976 | Probiotic effects in allergic disease |
| Q37953487 | Probiotic fermentation of plant based products: possibilities and opportunities. |
| Q37240389 | Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults |
| Q35631749 | Probiotic lactic acid bacteria and their potential in the prevention and treatment of allergic diseases. |
| Q43933317 | Probiotic research: learn from the evidence |
| Q36250265 | Probiotic therapy as a novel approach for allergic disease |
| Q35581031 | Probiotic use in children |
| Q59054619 | Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma |
| Q34046804 | Probiotics - the versatile functional food ingredients |
| Q41811148 | Probiotics and allergy: Current understanding and application for the PCCP (Primary Care Chiropractic Physician) |
| Q37148768 | Probiotics and atopic dermatitis in children |
| Q78452764 | Probiotics and atopic dermatitis. A new strategy in atopic dermatitis |
| Q35012929 | Probiotics and health: new facts and ideas. |
| Q35520339 | Probiotics and human health: a clinical perspective |
| Q36885139 | Probiotics and prebiotics in infant nutrition |
| Q37781993 | Probiotics and prebiotics: clinical effects in allergic disease |
| Q36476720 | Probiotics and their fermented food products are beneficial for health |
| Q24244833 | Probiotics for induction of remission in Crohn's Disease |
| Q24242115 | Probiotics for induction of remission in Crohn's disease |
| Q39552223 | Probiotics for photoprotection |
| Q35205685 | Probiotics for preterm infants? |
| Q24241429 | Probiotics for treating eczema |
| Q93336628 | Probiotics for treating eczema |
| Q35907513 | Probiotics for treatment and primary prevention of allergic diseases and asthma: looking back and moving forward |
| Q34665500 | Probiotics in clinical conditions |
| Q37071265 | Probiotics in clinical practice: an overview |
| Q34516776 | Probiotics in health and disease in the pediatric patient |
| Q54746716 | Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. |
| Q24243561 | Probiotics in infants for prevention of allergic disease and food hypersensitivity |
| Q24245728 | Probiotics in infants for prevention of allergy and food hypersensitivity |
| Q28211907 | Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial |
| Q37053058 | Probiotics in the United States |
| Q36720527 | Probiotics in the atopic march: highlights and new insights |
| Q37915051 | Probiotics in the management of children with allergy and other disorders of intestinal inflammation |
| Q36869464 | Probiotics in the management of lung diseases |
| Q33920545 | Probiotics in the treatment and prevention of allergies in children |
| Q36834497 | Probiotics in the treatment and prevention of allergy in children |
| Q35542621 | Probiotics to enhance anti-infective defences in the gastrointestinal tract |
| Q35744173 | Probiotics, prebiotics and child health: where are we going? |
| Q33445442 | Probiotics. |
| Q38701813 | Probiotics: Potent Immunomodulatory Tool Against Allergy |
| Q36441502 | Probiotics: their role in the treatment and prevention of disease |
| Q35947061 | Promises and problems of functional foods |
| Q34533028 | Prophylactic effect of probiotics on the development of experimental autoimmune myasthenia gravis |
| Q33764060 | Prophylaxis of experimentally induced ovomucoid allergy in neonatal pigs using Lactococcus lactis |
| Q48485225 | Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis |
| Q34551840 | Proteomics and transcriptomics characterization of bile stress response in probiotic Lactobacillus rhamnosus GG. |
| Q46964206 | Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy |
| Q45033809 | Reduction of allergic airway eosinophilia by dietary raffinose in Brown Norway rats |
| Q28087466 | Risk and safety of probiotics |
| Q36912217 | Role of gut microbiota in early infant development. |
| Q37969586 | Role of gut microbiota in food tolerance and allergies. |
| Q43225079 | Role of intestinal Bifidobacterium pseudolongum in dietary fructo-oligosaccharide inhibition of 2,4-dinitrofluorobenzene-induced contact hypersensitivity in mice |
| Q46169098 | Safety of supplementing infant formula with long-chain polyunsaturated fatty acids and Bifidobacterium lactis in term infants: a randomised controlled trial. |
| Q38770847 | Seafood allergen-induced hypersensitivity at the microbiota-mucosal site: Implications for prospective probiotic use in allergic response regulation |
| Q51797248 | Selection of probiotic bacteria for prevention of allergic diseases: immunomodulation of neonatal dendritic cells. |
| Q34442237 | Sesame allergy: a growing food allergy of global proportions? |
| Q37262058 | Specific probiotics alleviate allergic rhinitis during the birch pollen season |
| Q43613350 | Suppression of T-cell activation by Lactobacillus rhamnosus GG-degraded bovine casein |
| Q26821790 | Synbiotics, probiotics or prebiotics in infant formula for full term infants: a systematic review |
| Q41111533 | Synbiotics-supplemented amino acid-based formula supports adequate growth in cow's milk allergic infants |
| Q44598779 | Systemic therapy of atopic dermatitis |
| Q36360555 | The 'microflora hypothesis' of allergic diseases |
| Q33940780 | The Effects of Lactobacillus rhamnosus on the Prevention of Asthma in a Murine Model |
| Q41790745 | The Potential Therapeutic Efficacy of Lactobacillus GG in Children with Food Allergies |
| Q33906857 | The extracellular proteome of Bifidobacterium animalis subsp. lactis BB-12 reveals proteins with putative roles in probiotic effects |
| Q38164343 | The immunomodulatory effect of probiotics beyond atopy: an update |
| Q44587821 | The immunomodulatory properties of viable Lactobacillus salivarius ssp. salivarius CECT5713 are not restricted to the large intestine. |
| Q34707023 | The impact of Lactobacillus plantarum WCFS1 teichoic acid D-alanylation on the generation of effector and regulatory T-cells in healthy mice |
| Q89554316 | The infant gut microbiome as a microbial organ influencing host well-being |
| Q33955655 | The influence of selected ingredients of dietary supplements on skin condition. |
| Q34665469 | The influence of yogurt/Lactobacillus on the innate and acquired immune response |
| Q36358186 | The innate immune system and its role in allergic disorders |
| Q35548901 | The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium “The Intelligent Intestine,” held in Paris, June 14, 2002 |
| Q53229798 | The investigation of probiotic potential of lactic acid bacteria isolated from traditional Mongolian dairy products. |
| Q38715033 | The microbiome and atopic eczema: More than skin deep. |
| Q46739929 | The neonatal gut harbours distinct bifidobacterial strains |
| Q39924727 | The role of probiotics in allergic diseases |
| Q36464625 | The role of probiotics in the management of allergic disease. |
| Q40098335 | The skin microbiome and immune system: Potential target for chemoprevention? |
| Q51778986 | The study to investigate the potential benefits of probiotics in yogurt, a patient-oriented, double-blind, cluster-randomised, placebo-controlled, clinical trial. |
| Q26823347 | The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts |
| Q48543528 | Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema: randomized controlled trial with follow-up until age 3 years |
| Q36824470 | Use of probiotics in pediatrics: rationale, mechanisms of action, and practical aspects |
| Q33546633 | Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data |
| Q38933737 | What is the evidence base for atopic eczema treatments? A summary of published randomized controlled trials. |
| Q28282226 | World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines |
| Q84577944 | [Inside-Out. Probiotics and atopic dermatitis] |
| Q81381926 | [Probiotics and prebiotics for the prevention and treatment of atopic eczema] |
Search more.